Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Reviews: Rapid! Rapid! Rapid! …and systematic

Open access
Schünemann, Holger J, Moja, Lorenzo · 2015 · Systematic Reviews

Abstract

“Although time is a reality, lack of time is not lack ofreality” - HOJESSystematic reviewsSystematic reviews are scientific investigations, with pre-planned methods and an assembly of original studies astheir “subjects” [1,2]. They synthesize the results of mul-tiple primary investigations by using strategies that limitbias and random error [1,2]. Systematic reviews aretransparent about how studies were identified and whichwere included or excluded, the risk of bias assessment,and the methods to summarize data and assess the cer-tainty in the evidence. Standards for the conduct of sys-tematic reviews have been made available by theCochrane Collaboration and other organizations. If sys-tematic reviews are done well, e.g., by adhering to con-duct (e.g., Cochrane Handbook for Systematic Reviewsof Interventions) and reporting (e.g., PRISMA State-ment) best practice standards, it is not sensible to ques-tion the value of systematic reviews as a source ofinformation for shaping decision making [3,4]. Thismethodology of systematic reviews—although laid outthree or more decades ago—is continuously and rapidlyupdated by scientists specializing in research synthesis.Now, Systematic Reviews is publishing a series of articlesincluding methods and examples of accelerating ap-proaches to conducting literature reviews. As a rule ofthumb, rapid systematic reviews should be conducted inless than 8 weeks, including protocol publication. Onthe whole, this is a saving of about 75% in terms of timecompared to what most researchers would propose asstandard timeline for systematic reviews. Examples willhighlight how health policy decisions can be influencedwhen a rapid review methodology is used.The challenge of traditional systematic reviewsFindings from a single randomized trial are often rapidlychallenged by succeeding studies, and rigorous systematicreviews help approximate “true evidence” and estimatesin effects [5]. High-quality systematic reviews are usedmore often and are considered more trustworthy byhealth professionals in terms of relevance to clinical prac-tice than other types of designs [6]. However, conductingand adhering to the standards of traditional systematic re-views can be time consuming. The reason for that lies inthe rigorous approach to methods ensuring that the bestavailable evidence is identified, assessed, and synthesized.But those demanding evidence syntheses for decisionmaking are increasingly living in faster paced times, influ-enced by innovative interventions and technology that ac-celerate communication and interaction. Decision makersoften do not appreciate the intricacies of researchmethods and the time needed to comply with the task.The argument that transparency is ensured by completinga traditional systematic reviews is often not convincingenough. But there are other reasons.The rationale for rapid —systematic reviewsThe concern regarding a timely decision on health care andpolicies is the driving force for rapid reviews. In fact, deci-sion making should not be delayed in most situations andcannot be delayed in some. In the face of a tragic Ebola epi-demic, we are reminded of how rapidly answers are re-quired. To base answers on the best available evidence, thisevidence must be synthesized without undue delays. Whiletypical systematic reviews can take years to complete (oneof the author was involved in a systematic review that took12 years to complete), rapid reviews are required when fa-cing such dramatic situations. Prior to the Ebola epidemic,the fear of avian influenza prompted the World HealthOrganization to offer rapid guidelines that were supportedby a rapid review methodology. From guideline panel for-mation to completion of the recommendations, only about12 weeks passed [7]. Another recent rapid systematic re-view was commissioned to inform decision making with re-gard to the safety of two drugs, bevacizumab (Avastin) andranibizumab (Lucentis), widely used to stabilize vision in

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2046-4053-4-4

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 184

Metadata

Authors
Schünemann, H. J., & Moja, L.
Affiliations
  • McMaster University (CA)
  • University of Milan (IT)
Corresponding author
Schünemann, Holger J
Venue
Systematic Reviews
Published
2015-01-14
Volume
4
Issue
1
Pages
4-4
ISSN
2046-4053 (ISSN-L)
OpenAlex
W2159752579
Cited by
166
References
10
Citations by year
2026: 4 · 2025: 6 · 2024: 16 · 2023: 11 · 2022: 18 · 2021: 24 · 2020: 27 · 2019: 11 · 2018: 19 · 2017: 10 · 2016: 14 · 2015: 6
Type
journal article
Language
en
Open access
Locations
  • Systematic Reviews (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Social Sciences › Sociology and Political Science › Delphi Technique in Research
Keywords
evidence synthesis, health policy decision-making, Cochrane Handbook, PRISMA, risk of bias assessment, research transparency, health technology assessment
MeSH terms
Humans, Review Literature as Topic, Time Factors, Databases, Factual, Information Storage and Retrieval, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reviews: Rapid! Rapid! Rapid! …and systematic. https://app.cochat.ai/papers/10.1186/2046-4053-4-4
The paper
Schünemann, H. J., & Moja, L. (2015). Reviews: Rapid! Rapid! Rapid! …and systematic. Systematic Reviews. https://doi.org/10.1186/2046-4053-4-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.